Actavis first entered the Irish market in 2008 with just 15 products and a commitment to provide Irish retail and hospital pharmacists with long-term sustainable value across a broad product portfolio and outstanding customer service.
This commitment based on a partnership approach with pharmacists has helped Actavis to grow to be a leading generic supplier with a portfolio of over 100 products (250+ skus) across a range of therapeutic areas from the central nervous system, gastroenterology, women’s health, urology, cardiovascular, respiratory and anti-infective therapeutic categories.
Actavis has been one of the fastest growing generic companies on the Irish market for some time with double digit growth in the past 12 months; this reflects a 19% generics market share (IMS Health, July 2016).
Actavis prides itself on its best in market nationwide distribution channels; its ability to adapt to market volatility, its consistency of supply, its ability to supply over 70% of the molecules on the generic substitutable list and its quality products sourced within Europe.
Approximately 9 million packs of Actavis medicine are distributed in Ireland each year. Every 4 seconds a patient somewhere in Ireland takes an Actavis medicine. Actavis takes this responsibility of providing Irish patient’s with high quality products very seriously and will continue to offer value, choice, service & support to its range of valued customers across the country into the future.
Actavis Your Preferred Partner.
The Actavis Code of Conduct
The Code of Conduct provides an overview of the legal, regulatory and ethical requirements of our business.
It defines the way we conduct our affairs with each other and with all our stakeholders - our patients and customers, healthcare professionals, business partners, contractors,
investors, government officials and regulators and the diverse communities where we do business.
Actavis Ireland & The UK Code of Conduct